Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies"

  • Carolyn G Marsden1,
  • Mary Jo Wright2,
  • Latonya Carrier3,
  • Krzysztof Moroz4,
  • Radhika Pochampally5 and
  • Brian G Rowan6Email author
BMC Cancer201212:10

DOI: 10.1186/1471-2407-12-10

Received: 12 October 2011

Accepted: 10 January 2012

Published: 10 January 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Nov 2011 Reviewed Reviewer Report - Claudia Lengerke
14 Nov 2011 Reviewed Reviewer Report - Olle Stal
23 Nov 2011 Author responded Author comments - Carolyn Marsden
Resubmission - Version 3
23 Nov 2011 Submitted Manuscript version 3
6 Dec 2011 Reviewed Reviewer Report - Olle Stal
8 Dec 2011 Reviewed Reviewer Report - Claudia Lengerke
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Jan 2012 Editorially accepted
10 Jan 2012 Article published 10.1186/1471-2407-12-10

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Structural and Cellular Biology, Tulane University Health Sciences Center, The Louisiana Cancer Research Consortium
(2)
Department of Surgery, Tulane University School of Medicine, The Louisiana Cancer Research Consortium
(3)
Department of Structural and Cellular Biology, Tulane University Health Sciences Center
(4)
Section of Surgical Pathology & Cytopathology, Tulane University School of Medicine, Louisiana Cancer Research Consortium
(5)
Department of Pharmacology, Tulane University Health Sciences Center, Center for Gene Therapy, Louisiana Cancer Research Consortium
(6)
Department of Structural and Cellular Biology, Tulane University Health Sciences Center, Louisiana Cancer Research Consortium, Center for Gene Therapy

Advertisement